ArticleAnnals of translational medicine2022

Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation.

Xiaoting Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.